TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis

被引：1
|
作者：
Even, C. [1 ]
Daste, A. [2 ]
Fayette, J. [3 ]
Lefebvre, G. [4 ]
Saada-Bouzid, E. [5 ]
Zanetta, S. [6 ]
Toullec, C. [7 ]
Cupissol, D. [8 ]
Salas, S. [9 ]
Kaminski, M. C. [10 ]
Johnson, A. C. [11 ]
Vauleon, E. [12 ]
Le Tourneau, C. [13 ]
Sire, C. [14 ]
Prevost, A. [15 ]
Jallut, I. [16 ]
Bourhis, J. [17 ]
Guigay, J. [18 ]
Auperin, A. [19 ]
Texier, M. [20 ]
机构：
[1] Inst Gustave Roussy, Dept Carcinol Cervicofaciale, Villejuif, France
[2] CHU Bordeaux Hop St Andre, Gironde, Bordeaux, France
[3] Ctr Leon Berard, Med, Lyon, France
[4] Oscar Lambret Ctr, Head & Neck Thorac Oncol, Lille, France
[5] Ctr Anticancer Antoine Lacassagne, Med Oncol, Marseille, France
[6] Ctr Georges Francois Leclerc Dijon, Med Oncol Dept, Dijon, France
[7] Inst Sainte Catherine, Digest Oncol, Avignon, France
[8] Val dAurelle, Med, Montpellier, France
[9] AP HM, Med Oncol, Marseille, France
[10] Inst Cancerol Lorraine, Med Oncol, Vandoeuvre Les Nancy, France
[11] Ctr Francois Baclesse, Breast Head & Neck, Caen, France
[12] Ctr Eugene Marquis, Med Oncol, Rennes, France
[13] Inst Curie, Dept Drug Dev & Innovat D3i, Paris, France
[14] CHU Bretagne Sud, Lorient, France
[15] Inst Jean Godinot, Med Oncol, Reims, France
[16] UNICANCER, Head & Neck Grp, Paris, France
[17] CHUV Ctr Hosp Univ Vaudois, Radiat Oncol, Lausanne, Switzerland
[18] Ctr Anticancer Antoine Lacassagne, Dept Med Oncol, Nice, France
[19] Univ Paris Saclay, Inst Gustave Roussy, Dept Biostat & Epidemiol, Team Oncostat,CESP,U1018,Inserm, Villejuif, France
[20] Inst Gustave Roussy, Biostat, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
917MO
引用
收藏
页码：S662 / S662
页数：1
相关论文
共 50 条
  • [1] TOPNIVO: A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): First results on behalf of the UNICANCER Head&Neck Group and the GORTEC
    Even, C.
    Daste, A.
    Saada-Bouzid, E.
    Fayette, J.
    Kaminsky-Forrett, M-C.
    Zanetta, S.
    Prevost, A.
    Lefebvre, G.
    Borel, C.
    Cupissol, D.
    Huguet, F.
    Delord, J-P.
    Rotllan, N. Baste
    Delaye, J.
    Jallut, I.
    Vintonenko, N.
    Bourhis, J.
    Guigay, J.
    Texier, M.
    Auperin, A.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 380 - 380
  • [2] A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): Interim analysis on 199 patients-The TOPNIVO study on behalf of the GORTEC and the Unicancer Head & Neck Group.
    Even, Caroline
    Daste, Amaury
    Saada-Bouzid, Esma
    Lefebvre, Gautier
    Fayette, Jerome
    Zanetta, Sylvie
    Kaminsky, Marie-Christine
    Cupissol, Didier
    Prevost, Alain
    Vauleon, Elodie
    Johnson, Alison Claire
    Salas, Sebastien
    Rolland, Frederic
    David, Miruna Timar
    Jallut, Isabelle
    Delaye, Jessy
    Bourhis, Jean
    Guigay, Joel
    Texier, Matthieu
    Auperin, Anne
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Efficacy and safety of nivolumab (Nivo) in recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): A real-world data study
    Soto Castillo, J. J.
    Esteban Villarrubia, J.
    Alvarez Ballesteros, P.
    Garrido Lopez, P.
    Soria Rivas, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1438 - S1438
  • [4] Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
    Okada, Takuro
    Matsuki, Takashi
    Fushimi, Chihiro
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Tokashiki, Kunihiko
    Ito, Tatsuya
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Kouki
    Hanyu, Kenji
    Omura, Go
    Takahashi, Hideki
    Yamashita, Taku
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    [J]. ANTICANCER RESEARCH, 2022, 42 (10) : 4907 - 4912
  • [5] Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Zenda, Sadamoto
    Onozawa, Yusuke
    Boku, Narikazu
    Fida, Yoshiyuki
    Ebihara, Mitsuru
    Onitsuka, Tetsuro
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (07) : 477 - 481
  • [6] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Byoung Chul Cho
    Ki Chang Keum
    Sang Joon Shin
    Hye Jin Choi
    Young Joo Lee
    Se Hun Kim
    Eun Chang Choi
    Joo Hang Kim
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 65 : 27 - 32
  • [7] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Cho, Byoung Chul
    Keum, Ki Chang
    Shin, Sang Joon
    Choi, Hye Jin
    Lee, Young Joo
    Kim, Se Hun
    Choi, Eun Chang
    Kim, Joo Hang
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 27 - 32
  • [8] Nivolumab Versus Investigator'S Choice (IC) for Platinum-Refractory Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN; CHECKMATE 141): Outcomes in First-Line R/M Patients and Updated Safety and Efficacy
    Gillison, Maura L.
    Blumenschein, George, Jr.
    Fayette, Jerome
    Guigay, Joel
    Colevas, A. Dimitrios
    Licitra, Lisa
    Harrington, Kevin J.
    Kasper, Stefan
    Vokes, Everett E.
    Even, Caroline
    Worden, Francis
    Saba, Nabil F.
    Iglesias Docampo, Lara Carmen
    Haddad, Robert
    Rordorf, Tamara
    Kiyota, Naomi
    Tahara, Makoto
    Lynch, Mark
    Kopit, Justin
    Ferris, Robert L.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 144 - 144
  • [9] EFFICIENCY OF NIVOLUMAB TREATMENT AFTER PLATINUM CHEMOTHERAPY IN RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (R/M SCCHN) IN SPAIN
    Suarez, J.
    Juarez-Garcia, A.
    Shaw, J. W.
    Contente, M.
    Polanco, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S18 - S19
  • [10] Efficacy and safety of nivolumab for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in Asia: CheckMate 141 subgroup analysis
    Hasegawa, Y.
    Kiyota, N.
    Takahashi, S.
    Yokota, T.
    Yen, C-J.
    Iwae, S.
    Shimizu, Y.
    Hong, R-L.
    Goto, M.
    Namba, Y.
    Ferris, R. L.
    Monga, M.
    Lynch, M.
    Hagihara, S.
    Tahara, M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345